NEW YORK (TheStreet) -- RATINGS CHANGES

Ambarella (AMBA) - Get Report was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: AMBA Ratings Report

Amira Nature Foods (ANFI) - Get Report was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: ANFI Ratings Report.

Watch the video below for more of Monday's analysts' actions:

Dana (DAN) - Get Report was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is $20. Company lacks catalysts and may fail to meet consensus expectations, RBC Capital said.

Dover (DOV) - Get Report was downgraded at Robert Baird to neutral from outperform. Twelve-month price target is $85. Softer energy prices may weigh on growth, Robert Baird said.

Endo Health Solutions (ENDP) - Get Report was upgraded at Cantor Fitzgerald to hold. Auxilium Pharmaceuticals (AUXL) deal should be accretive to EPS with longer-term increases in EBITDA, possibly facilitating additional M&A, Cantor said.

Freescale Semi (FSL) was downgraded at Pacific Crest to sector perform, said Pacific Crest. Weak China demand is resulting in a correction at Asian distributors, Pacific Crest said.

Graco (GGG) - Get Report was upgraded at Oppenheimer to outperform from perform. Valuation call, based on a 12-month price target of $79.

Henry Schein (HSIC) - Get Report was upgraded at ISI Group to buy from neutral. Twelve-month price target is $131. The stock has lagged, but the company can continue to deliver solid growth, ISI Group said.

Johnson Controls (JCI) - Get Report was downgraded at RBC Capital to outperform from top pick. Twelve-month price target is $49. Company lacks near-term catalysts, RBC Capital said.

On Semiconductor (ONNN) was downgraded at Pacific Crest to sector perform. Weak China demand is resulting in a correction at Asian distributors, Pacific Crest said.

Parker Hannifin (PH) - Get Report was downgraded at Wells Fargo to market perform from outperform. Company is likely to face growth headwinds both overseas and in the U.S., Wells Fargo said.

Parker Hannifin was downgraded at Robert Baird to neutral from outperform. Twelve-month price target is $115. Company will likely be hurt by lower energy prices, Robert Baird said.

Silicon Laboratories (SLAB) - Get Report was downgraded at Pacific Crest to sector perform. Weak China demand is resulting in a correction at Asian distributors, Pacific Crest said.

Vertex (VRTX) - Get Report was upgraded at Piper Jaffray to overweight from neutral. Twelve-month price target is $125. Expect combination approvals in 2015, Piper Jaffray said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.